Interleukin 6 plasma levels are associated with progression of coronary plaques
Plasma IL-6 levels are significantly associated with increased total and noncalcified short-term plaque progression in patients with stable coronary artery disease. This supports the potential of IL-6 as a target for reducing plaque progression and cardiovascular risk.
Authors
- Jordan M Kraaijenhof (ORCID: https://orcid.org/0000-0001-7566-6403)
- Evangelos Tzolos (ORCID: https://orcid.org/0000-0003-0038-043X)
- Jolien Geers (ORCID: https://orcid.org/0000-0003-1109-5191)
- Nick S. Nurmohamed (ORCID: https://orcid.org/0000-0001-9045-6009)
- Yannick Kaiser (ORCID: https://orcid.org/0000-0001-6869-0042)
- G Kees Hovingh
- Jeffrey Kroon (ORCID: https://orcid.org/0000-0001-9983-6614)
- Erik S.G. Stroes (ORCID: https://orcid.org/0000-0001-9555-6260)
- Mo Meah
- Marc R Dweck
Institutions
- Vrije Universiteit Brussel (BE)
- British Heart Foundation (GB)
- VIB-KU Leuven Center for Cancer Biology (BE)
- Universitair Ziekenhuis Brussel (BE)
- Amsterdam University Medical Centers (NL)
- Vrije Universiteit Amsterdam (NL)
- University of Amsterdam (NL)
- University of Edinburgh (GB)
- KU Leuven (BE)
Publication Details
- Journal
- Open Heart
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1136/openhrt-2024-002773
- Citations
- 8
- Primary Topic
- Cardiac Imaging and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 3.23
Funders
- Heart Foundation
- European Atherosclerosis Society